Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003715
Status:
TERMINATED
Last Update Posted:
2015-12-03
First Post:
1999-11-01
Brief Title:
Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
Sponsor:
AVAX Technologies
Organization:
AVAX Technologies
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Melanoma Skin |
Keywords:
| Name | View |
|---|---|
| stage III melanoma | View |